MedTrace Logo

Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis.

NCT00204022 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2011-10-14

No results posted yet for this study

Summary

The purpose of the study is to determine whether mycophenolate mofetil is superior to azathioprine to prevent flares of lupus nephritis.

Conditions

Interventions

DRUG

Mycophenolate mofetil

Mycophenolate mofetil

DRUG

Azathioprine

Azathioprine

Sponsors & Collaborators

  • Frédéric A. Houssiau, MD, PhD

    lead OTHER

Principal Investigators

  • Frédéric A Houssiau, MD, PhD · Université Catholique de Louvain

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-02-28
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00204022 on ClinicalTrials.gov